Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency Contraception

Fine, Paul; Mathe, Henri; Ginde, Savita; Cullins, Vanessa; Morfesis, Johanna; Gainer, Erin

doi:10.1097/aog.0b013e3181c8e2aa

Cited by 141 publications

(90 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…44,134 Ulipristal acetate may have greater effectiveness than oral levonorgestrel at the end of the 5-day window of use, and its remaining effectiveness and adverse effect profile are similar to those of levonorgestrel. 135,136 In addition, on the basis of recent data about lower efficacy of levonorgestrel EC, ulipristal may be more effective in people who weigh more than 165 pounds. 137,138 Placement of a copper-bearing IUD is less commonly used for EC in adolescents but is the most effective EC method, with a failure rate of less than 1%.…”

Section: Emergency Contraceptionmentioning

confidence: 99%

Contraception for Adolescents

Braverman¹,

Adelman²,

Alderman³

et al. 2014

Pediatrics

311

107

View full text Add to dashboard Cite

Contraception is a pillar in reducing adolescent pregnancy rates. The American Academy of Pediatrics recommends that pediatricians develop a working knowledge of contraception to help adolescents reduce risks of and negative health consequences related to unintended pregnancy. Over the past 10 years, a number of new contraceptive methods have become available to adolescents, newer guidance has been issued on existing contraceptive methods, and the evidence base for contraception for special populations (adolescents who have disabilities, are obese, are recipients of solid organ transplants, or are HIV infected) has expanded. The Academy has addressed contraception since 1980, and this policy statement updates the 2007 statement on contraception and adolescents. It provides the pediatrician with a description and rationale for best practices in counseling and prescribing contraception for adolescents. It is supported by an accompanying technical report.

show abstract

Section: Emergency Contraceptionmentioning

confidence: 99%

Contraception for Adolescents

Braverman¹,

Adelman²,

Alderman³

et al. 2014

Pediatrics

311

107

View full text Add to dashboard Cite

show abstract

“…Data suggest that ulipristal acetate, approved by the FDA in 2010, may have increased effectiveness over oral levonorgestrel at the end of the 5-day window of use and in heavier women. [208][209][210] On the basis of data demonstrating that the levonorgestrel EC pill loses effectiveness in women who weigh more than 165 pounds and is ineffective in women who weigh more than 176 pounds, the levonorgestrel EC pill is undergoing revised labeling in Europe, and the FDA is considering whether to require similar revisions in the United States. 211 Unlike ulipristal, which is pregnancy category X, levonorgestrel does not have teratogenic or other adverse effects on the fetus, 212 and a pregnancy test is not necessary before prescribing levonorgestrel EC.…”

Section: Male Condomsmentioning

confidence: 99%

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

245

133

View full text Add to dashboard Cite

A working knowledge of contraception will assist the pediatrician in both sexual health promotion as well as treatment of common adolescent gynecologic problems. Best practices in adolescent anticipatory guidance and screening include a sexual health history, screening for pregnancy and sexually transmitted infections, counseling, and if indicated, providing access to contraceptives. Pediatricians’ long-term relationships with adolescents and families allow them to help promote healthy sexual decision-making, including abstinence and contraceptive use. Additionally, medical indications for contraception, such as acne, dysmenorrhea, and heavy menstrual bleeding, are frequently uncovered during adolescent visits. This technical report provides an evidence base for the accompanying policy statement and addresses key aspects of adolescent contraceptive use, including the following: (1) sexual history taking, confidentiality, and counseling; (2) adolescent data on the use and side effects of newer contraceptive methods; (3) new data on older contraceptive methods; and (4) evidence supporting the use of contraceptives in adolescent patients with complex medical conditions.

show abstract

“…Gebelik oranları UPA grubunda %1,8 ve LNG grubunda %2,6 bulunmuştur ve sonuç olarak UPA anlamlı olarak daha fazla gebeliği önlemiştir şeklinde rapor edilmiştir 34 . Fine ve arkadaşlarının yayınladıkları prospektif, faz 3 çalışmada; UPA korunmasız cinsel ilişkiden sonraki 48-120 saatler arası kullanılmış ve buna rağmen beklenen gebelik oranının %5,5'ten %2,1'e düştüğü görülmüş; UPA korunmasız cinsel ilişkiden 120 saat sonrasına kadar kullanılabilinir şeklinde sonuç belirtilmiştir 35 . Klinik çalışmalardan da anlaşılacağı üzere UPA, LNG'den daha etkin bir acil kontraseptiftir (Tablo1).…”

Section: Mifepristonunclassified

“…UPA kullanımında görülen yan etkiler; baş ağrısı (%18), bulantı (%12), karın ağrısı (%12), daha az görülen yan etkiler ise adet sancısı, yorgunluk, baş dönmesi olarak sıralanabilir. Diğer bir yan etkisi menstruasyondaki gecikmedir 34,35 . Gebelikte fetus üzerine etkileri hakkında yeterli veri yoktur, hayvan çalışmalarında teratojenik etki saptanmamıştır.…”

Section: Mifepristonunclassified

Emergency Contraception

Taşkın¹

2015

BSBD

View full text Add to dashboard Cite

ÖZETAcil kontrasepsiyon, korunmasız bir cinsel ilişki sonrası uygulanan kontraseptif metotdur, böylelikle düzenli bir kontrasepsiyon metodu değildir. Acil kontrasepsiyon için değişik yaklaşımlar mevcut olup bunların başlıcaları: mifepriston, ulipristal asetat ve levonorgestrel gibi ilaçlar veya rahim içi araçlardır. Bu derlemede sizlere acil kontrasepsiyon ile ilgili güncel bilgileri sunmayı amaçladım.Anahtar Kelimeler: Kontrasepsiyon, Levonorgestrel, Ulipristal asetat, Rahim içi araç. SUMMARYEmergency contraception is a type of contraceptive methods that is used after unprotected intercourse, thus, this is not a suitable method for regular contraception. There are different approaches for emergency contraception mainly; drugs such as mifepristone, ulipristal acetate and levonorgestrel, or intrauterine devices (IUDs). In this review I would like to present an updated knowledge about emergency contraception.

show abstract

Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency Contraception

Abstract: II.

Cited by 141 publications

References 12 publications

Contraception for Adolescents

Contraception for Adolescents

Contraception for Adolescents

Emergency Contraception

Contact Info

Product

Resources

About